Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping
ContributorsFontana, Pierre; Cattaneo, Marco; Combescure, Christophe ; Reny, Jean-Luc
Published inJournal of the American Heart Association. Cardiovascular and cerebrovascular disease, vol. 2, no. 2, e000131
Publication date2013
Abstract
Research group
Citation (ISO format)
FONTANA, Pierre et al. Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping. In: Journal of the American Heart Association. Cardiovascular and cerebrovascular disease, 2013, vol. 2, n° 2, p. e000131. doi: 10.1161/JAHA.112.000131
Main files (1)
Article (Published version)
Identifiers
- PID : unige:29632
- DOI : 10.1161/JAHA.112.000131
- PMID : 23537811
ISSN of the journal2047-9980